MALAT1 and diabetes mellitus: Interestingly, intraocular injections of a MALAT1 short hairpin RNA (shRNA) in the diabetic rats significantly alleviated diabetes-induced retinal inflammation, retinal cell apoptosis, vascular leakage, and electroretinogram abnormalities.